Cargando…
Randomized Versus Real-World Evidence on the Efficacy and Toxicity of Checkpoint Inhibitors in Cancer in Patients with Advanced Non-small Cell Lung Cancer or Melanoma: A Meta-analysis
BACKGROUND: Both randomized controlled trials (RCTs) and real-world evidence (RWE) studies provide results regarding the efficacy and toxicity of checkpoint inhibitors in cancer patients. The results from these two sources are considered complementary but whether they are comparable remains unknown....
Autores principales: | Digkas, Evangelos, Tabiim, Anthony Jagri, Smith, Daniel, Valachis, Antonis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9512877/ https://www.ncbi.nlm.nih.gov/pubmed/35913645 http://dx.doi.org/10.1007/s11523-022-00901-1 |
Ejemplares similares
-
Improved survival without increased toxicity with influenza vaccination in cancer patients treated with checkpoint inhibitors
por: Valachis, Antonios, et al.
Publicado: (2021) -
Predicting immune‐related adverse events using a simplified frailty score in cancer patients treated with checkpoint inhibitors: A retrospective cohort study
por: Olsson Ladjevardi, Cecilia, et al.
Publicado: (2023) -
Effectiveness and Safety of Immune Checkpoint Inhibitors for Patients with Advanced Non Small-Cell Lung Cancer in Real-World: Review and Meta-Analysis
por: Mencoboni, Manlio, et al.
Publicado: (2021) -
Mammographic Density Changes over Time and Breast Cancer Risk: A Systematic Review and Meta-Analysis
por: Mokhtary, Arezo, et al.
Publicado: (2021) -
Influenza vaccination in breast cancer patients during subcutaneous trastuzumab in adjuvant setting
por: Joona, Therse Björkin, et al.
Publicado: (2020)